Ensign Peak Advisors, Inc Olema Pharmaceuticals, Inc. Transaction History
Ensign Peak Advisors, Inc
- $55.3 Billion
- Q4 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 18,849 shares of OLMA stock, worth $93,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,849
Previous 18,849
-0.0%
Holding current value
$93,679
Previous $225,000
51.56%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding OLMA
# of Institutions
162Shares Held
71.9MCall Options Held
251KPut Options Held
6.7K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$37.1 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$36.3 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$28.4 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$18.2 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $201M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...